Status:
WITHDRAWN
Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization
Lead Sponsor:
Asociación para Evitar la Ceguera en México
Collaborating Sponsors:
Centro Medico Issemym
Conditions:
Subfoveal Choroidal Neovascularization
Eligibility:
All Genders
20-90 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to compare the efficacy of photodynamic therapy with verteporfin (PDT) and IVTA vs triple therapy (TT) in patients with subfoveal choroidal neovascularization (CNV) second...
Detailed Description
Purpose: To compare the efficacy of photodynamic therapy with verteporfin (PDT) and IVTA vs triple therapy (TT) in patients with subfoveal choroidal neovascularization (CNV) secondary to age-related m...
Eligibility Criteria
Inclusion
- Subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD)
- Any visual acuity
Exclusion
- Previous treatment
- Glaucoma
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00930189
Start Date
April 1 2006
End Date
September 1 2006
Last Update
May 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Medico Isemmym
Metepec, State of Mexico, Mexico, 52140